Viewing Study NCT04269551


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2025-12-31 @ 1:43 PM
Study NCT ID: NCT04269551
Status: COMPLETED
Last Update Posted: 2025-09-22
First Post: 2020-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease
Sponsor: Bioverativ, a Sanofi company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module